Parkinson's disease is a progressive and debilitating disorder that has so far eluded
attempts to develop disease‐modifying treatment. Both epidemiological and genetic studies …

Neuroinflammation plays a crucial role in the pathogenesis of Parkinson's disease (PD), but
controversies persist. Studies reporting concentrations of blood or cerebrospinal fluid (CSF) …

Although, current medications for Parkinson's disease can control and relief symptoms of the
disease efficiently, they are unable to either prevent progression of the disease or maintain …

Parkinson's disease (PD) is characterized by the progressive loss of midbrain dopaminergic
(mDA) neurons and a subsequent decrease in striatal dopamine levels, which cause the …

Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic
neurons in the substantia nigra pars compacta (SNpc). Although the exact cause of the …

Parkinson's disease (PD) is a type of motor system disorder that results from the progressive
loss of dopaminergic (DAergic) neurons in the substantia nigra (SN) of the midbrain. It is one …

Publisher Summary Parkinson's disease (PD) is the second most frequent
neurodegenerative disorder of the aging brain after Alzheimer's dementia. Its clinical …

Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …

Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. It is
characterized by the accumulation of α-Synuclein aggregates and the degeneration of …

Neurodegenerative disorders encompass a range of conditions in which neuronal structure
and function are altered affecting the brain and spinal cord [central nervous system (CNS)] …